Transcriptomic Insights Into Alzheimer's Disease: Differentially Expressed Genes and Cholesterol Metabolism.
Overview
- Department of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui China
- Department of Anesthesiology Graduate School of Bengbu Medical University Bengbu Anhui China
Abstract
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory impairment, posing significant challenges to affected individuals, their families, and healthcare systems globally. With projections indicating that the prevalence of AD could escalate to 152 million cases by 2050, there is an urgent need to elucidate the underlying mechanisms driving this condition. Additionally, developing effective diagnostic tools to aid in its early detection and management is crucial.
Methods: In this study, we utilized a combination of Mendelian randomization and advanced machine learning techniques to analyze transcriptomic data from five distinct cohorts of Alzheimer's Disease (AD) patients. After addressing batch effects, we identified differentially expressed genes (DEGs) between the AD and control groups. Mendelian randomization analysis was conducted to assess the causal relationships between DEGs and AD risk. A Venn diagram was subsequently used to identify genes associated with cholesterol metabolism from the screened gene set. The shared DEGs were subjected to functional enrichment analyses. Furthermore, immune analysis was quantified using Gene Set Enrichment Analysis (GSEA). A diagnostic model for AD was developed by evaluating 113 combinations of 12 machine learning algorithms with 10‐fold cross‐validation on the training datasets, followed by external validation on test datasets. Finally, immunofluorescence staining was performed on mouse brain slices to verify the expression level of KLHL21.
Results: Our analyses identified a substantial number of differentially expressed genes (DEGs) demonstrating significant differences between Alzheimer's disease (AD) patients and control groups. Among these, we identified 29 genes associated with AD, with 21 of them linked to cholesterol metabolism, highlighting its pivotal role in the disease's pathogenesis. From this set, we developed a robust 8‐gene diagnostic signature (comprising CHSY1, FIBP, DHCR24, HVCN1, KIFAP3, KLHL21, LETMD1, and SLC25A29), which outperformed existing AD diagnostic models in both training and testing cohorts. Additionally, complementary animal experiments were conducted to validate the biological relevance of these genes, further elucidating their roles in AD pathology.
Conclusions: Our research identified critical genes and proposed novel pathways for early diagnosis and potential therapeutic interventions, paving the way for enhanced clinical applications in Alzheimer's disease management.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- zenodo:18289856, at Zenodo; found in “Data Availability Statement”
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in the text, “Data Collection”
Data Availability Statement
The data that support the findings of this study are openly available in sun00814/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 30 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 9 authors, 4 keywords, 12 MeSH terms, 3 funders, 39 references.
Cite
This paper
Sun, R., Wang, X., Wang, Z., Li, C., Shao, Q., Liu, X., Zhu, H., Wang, S., & He, K. (2026). Transcriptomic Insights Into Alzheimer's Disease: Differentially Expressed Genes and Cholesterol Metabolism. CNS neuroscience & therapeutics, 32(3), e70833. https://
BibTeX
@article{sun2026transcri
author = {Sun, Rui and Wang, Xu and Wang, Zaibao and Li, Chunliu and Shao, Qing and Liu, Xiangru and Zhu, Hongrui and Wang, Sheng and He, Keqiang},
title = {{Transcriptomic Insights Into Alzheimer's Disease: Differentially Expressed Genes and Cholesterol Metabolism}},
journal = {CNS neuroscience \& therapeutics},
year = {2026},
month = mar,
volume = {32},
number = {3},
pages = {e70833},
publisher = {Wiley},
issn = {1755-5930},
doi = {10.1002/
url = {https://
pmid = {41854441},
pmcid = {PMC13093267}
}
RIS
TY - JOUR
AU - Sun, Rui
AU - Wang, Xu
AU - Wang, Zaibao
AU - Li, Chunliu
AU - Shao, Qing
AU - Liu, Xiangru
AU - Zhu, Hongrui
AU - Wang, Sheng
AU - He, Keqiang
TI - Transcriptomic Insights Into Alzheimer's Disease: Differentially Expressed Genes and Cholesterol Metabolism
T2 - CNS neuroscience & therapeutics
J2 - CNS Neurosci Ther
PY - 2026
DA - 2026/
VL - 32
IS - 3
SP - e70833
SN - 1755-5930
PB - Wiley
DO - 10.1002/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1002/
"type": "article-journal",
"title": "Transcriptomic Insights Into Alzheimer's Disease: Differentially Expressed Genes and Cholesterol Metabolism",
"container-title": "CNS neuroscience & therapeutics",
"author": [
{
"family": "Sun",
"given": "Rui"
},
{
"family": "Wang",
"given": "Xu"
},
{
"family": "Wang",
"given": "Zaibao"
},
{
"family": "Li",
"given": "Chunliu"
},
{
"family": "Shao",
"given": "Qing"
},
{
"family": "Liu",
"given": "Xiangru"
},
{
"family": "Zhu",
"given": "Hongrui"
},
{
"family": "Wang",
"given": "Sheng"
},
{
"family": "He",
"given": "Keqiang"
}
],
"container-title-short":
"volume": "32",
"issue": "3",
"page": "e70833",
"DOI": "10.1002/
"PMID": "41854441",
"PMCID": "PMC13093267",
"ISSN": "1755-5930",
"publisher": "Wiley",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
1
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s13041-026-01312-3
- Sevoflurane ameliorates cerebral ischemia-reperfusion injury by modulating mitochondrial dynamics and attenuating apoptosis via Shh-YAP1 signaling pathway.Journal: Molecular brainIn common: mouse, cellular / molecular, author Hongrui Zhu
- [2] doi:10.1038/s41593-026-02267-3 [code]
- Spatial proteomic analysis in human Alzheimer's disease brains enables identification of microenvironment-depende
nt microglial cell states. Journal: Nature neuroscienceIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 3 references - [3] doi:10.1002/alz.71804
- A meta-refined human Alzheimer's disease-associated gene subset shows partial mouse-model pathway correspondence and limited cross-cohort machine-learning transportability.Journal: Alzheimer's & dementia : the journal of the Alzheimer's AssociationIn common: Alzheimer's / dementia, genetics / omics, mouse, 1 other category, 3 references
- [4] doi:10.1038/s43587-026-01204-0
- Fibronectin mediates APOE4-driven blood-brain barrier dysfunction in Alzheimer's disease.Journal: Nature agingIn common: Alzheimer's / dementia, genetics / omics, mouse, 1 other category, 2 references
- [5] doi:10.3390/brainsci16070757
- Low-Intensity Focused Ultrasound Alters Alzheimer's Disease Pathology, In Vivo, as a Function of Ultrasound Dose and Age.Journal: Brain sciencesIn common: Alzheimer's / dementia, mouse, 2 references
- [6] doi:10.1038/s41467-026-68864-9 [code]
- Integrative epigenomic landscape of Alzheimer's Disease brains reveals oligodendrocyte molecular perturbations associated with tau.Journal: Nature communicationsIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 2 references
- [7] doi:10.1093/braincomms/fcag326 [code]
- Brain multiomic profiling identifies tau-related transcriptomic dysregulation in Alzheimer's disease.Journal: Brain communicationsIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 2 references
- [8] doi:10.1186/s12967-026-08414-5 [code]
- Integrative transcriptomic analysis identifies meningeal-hippocampal immune communication in Alzheimer's disease.Journal: Journal of translational medicineIn common: Alzheimer's / dementia, genetics / omics, mouse, 1 other category, 2 references
- [9] doi:10.1016/j.isci.2026.117038 [code]
- Multi-region brain transcriptomes uncover two subtypes of aging individuals with differences in Alzheimer risk and the impact of &
lt;i& gt;APOEε4& lt;/ i& gt;. Journal: iScienceIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 2 references - [10] doi:10.1126/sciadv.aed6825
- SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain.Journal: Science advancesIn common: Alzheimer's / dementia, genetics / omics, mouse, 1 other category, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
